Abatacept Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Condition:   Thalassemia in Children Interventions:   Drug: Abatacept;   Drug: Sirolimus Sponsors:   The Hospital for Sick Children;   Thalassemia Foundation of Canada Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 21, 2022 Category: Research Source Type: clinical trials